Kraj: Malta
Język: angielski
Źródło: Medicines Authority
BACLOFEN
Syri Pharma Limited Floor 0 1 WML, 1 Windmill Lane Dublin 2, D02 F206, Ireland
M03BX01
BACLOFEN 10 mg/5ml
ORAL SOLUTION
BACLOFEN 10 mg/5ml
POM
MUSCLE RELAXANTS
Authorised
2019-09-12
Page 1 of 8 PACKAGE LEAFLET: INFORMATION FOR THE USER BACLOFEN THAME 10MG/5ML ORAL SOLUTION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Baclofen Thame 10mg/5ml Oral Solution but it will be referred to as ‘Baclofen’ throughout this leaflet. WHAT IS IN THIS LEAFLET: 1. What Baclofen is and what it is used for 2. What you need to know before you take Baclofen 3. How to take Baclofen 4. Possible side effects 5. How to store Baclofen 6. Contents of the pack and other information 1. WHAT BACLOFEN IS AND WHAT IT IS USED FOR Baclofen contains active ingredient baclofen. Baclofen is a muscle-relaxant drug. Baclofen is used to reduce and relieve the excessive tension in your muscles (spasms) occurring in various illnesses such as cerebral palsy, multiple sclerosis, cerebrovascular accidents, spinal cord diseases and other nervous system disorders. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BACLOFEN DO NOT TAKE BACLOFEN IF: you think you may be allergic to baclofen or to any of the other ingredients of the solution (these are listed at the end of the leaflet) you have ever had a stomach ulcer. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Baclofen if: you have had a stroke you suffer from epilepsy you suffer from any mental illness you are being treated for high blood pressure you have Parkinson’s disease you suffer from any liver, kidney or lung disease you have diabetes you have difficulties in urinating you are pregnant Przeczytaj cały dokument
VAR/IA-006 Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Baclofen Thame 10mg/5ml Oral Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml of oral solution contains 10mg of Baclofen. _Excipients with known effect:_ Each 5ml of oral solution contains 7mg methyl parahydroxybenzoate (E218), 1.925gm sorbitol (E420), 6.675mg propylene glycol (E1520) and 8.1mg of sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral Solution Clear, pale yellow to yellow colour solution with raspberry odour Sugar Free 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Baclofen is indicated for the relief of spasticity of voluntary muscle resulting from such disorders as: multiple sclerosis, other spinal lesions, e.g. tumours of the spinal cord, syringomyelia, motor neurone disease, transverse myelitis, traumatic partial section of the cord. Baclofen is also indicated in adults and children for the relief of spasticity of voluntary muscle arising from e.g. cerebrovascular accidents, cerebral palsy, meningitis, traumatic head injury. Patient selection is important when initiating Baclofen therapy; it is likely to be of most benefit in patients whose spasticity constitutes a handicap to activities and/or physiotherapy. Treatment should not be commenced until the spastic state has become stabilised. PAEDIATRIC POPULATION Baclofen is indicated in patients 0 to <18 years for the symptomatic treatment of spasticity of cerebral origin, especially where due to infantile cerebral palsy, as well as following cerebrovascular accidents or in the presence of neoplastic or degenerative brain disease. Baclofen is also indicated for the symptomatic treatment of muscle spasms occurring in spinal cord diseases of infectious, degenerative, traumatic, neoplastic, or unknown origin such as multiple sclerosis, spastic spinal paralysis, amyotrophic lateral sclerosis, syringomyelia, transverse myelitis, traumatic paraplegia or paraparesis, and compression of the spinal cord. VAR/IA-006 Przeczytaj cały dokument